Professor Brook Baker co-wrote an article, “From Business as Usual to Health for the Future: Challenging the Intellectual Property Regime to Address COVID-19 and Future Pandemics,” on the legal, political, and commercial obstacles that bar low- and middle-income countries from getting access to the pharmaceutical products needed to protect their populations during a pandemic.
